Main menu
- Home
- Drugs of Abuse
- Commonly Abused Drugs Charts
- Emerging Trends and Alerts
- Alcohol
- Club Drugs
- Cocaine
- Fentanyl
- Hallucinogens
- Inhalants
- Heroin
- Marijuana
- MDMA (Ecstasy/Molly)
- Methamphetamine
- Opioids
- Over-the-Counter Medicines
- Prescription Medicines
- Steroids (Anabolic)
- Synthetic Cannabinoids (K2/Spice)
- Synthetic Cathinones (Bath Salts)
- Tobacco/Nicotine and E-Cigs
- Other Drugs
- Related Topics
- Addiction Science
- Adolescent Brain
- Comorbidity
- College-Age & Young Adults
- Criminal Justice
- Drugged Driving
- Drug Testing
- Drugs and the Brain
- Genetics
- Global Health
- Health Consequences of Drug Misuse
- Hepatitis (Viral)
- HIV/AIDS
- Mental Health
- Military
- Opioid Overdose Reversal with Naloxone (Narcan, Evzio)
- Pain
- Prevention
- Recovery
- Substance Use and SUDs in LGBT Populations
- Treatment
- What to Do If You Have a Problem with Drugs: For Teens and Young Adults
- What to Do If You Have a Problem with Drugs: For Adults
- What to Do If Your Teen or Young Adult Has a Problem with Drugs
- What to Do If Your Adult Friend or Loved One Has a Problem with Drugs
- Intentional vs. Unintentional Overdose Deaths
- Trends & Statistics
- Women and Drugs
- Publications
- Funding
- Funding Opportunities
- Clinical Research
- Regulations, Policies, and Guidance
- Guidelines for Developing a Data and Safety Monitoring Plan
- Guidelines for Establishing and Operating a Data and Safety Monitoring Board
- NACDA Guidelines for Administration of Drugs to Human Subjects
- NACDA Guidelines for Substance Abuse Research Involving Children and Adolescents
- Bioethics
- Clinical Trials Information
- Post-Award Concerns
- General Information
- Grant & Contract Application Process
- Funding Priorities
- NIDA Funding Strategy
- NIDA Funding Strategy for Fiscal Year 2018
- NIDA Funding Strategy for Fiscal Year 2016
- NIDA Funding Strategy for Fiscal Year 2015
- NIDA Funding Strategy for Fiscal Year 2014
- NIDA Funding Strategy for Fiscal Year 2013
- NIDA Funding Strategy for Fiscal Year 2012
- NIDA Funding Strategy for Fiscal Year 2011
- NIDA Funding Strategy for Fiscal Year 2010
- NIDA Funding Strategy for Fiscal Year 2009
- NIDA Funding Strategy for Fiscal Year 2008
- NIDA Funding Strategy for Fiscal Year 2007
- NIDA Funding Strategy for Fiscal Year 2006
- NIDA Topics of Special/Continuing Interest (DAT)
- Technology Transfer
- NIDA Funding Strategy
- Research Training
- Extramural Research Training & Career Development
- High School and Undergraduates
- Predoctoral or Medical Students
- What to know about the Predoctoral Process
- Postdoctoral Researchers or Clinical Residents
- What to know about the Postdoctoral Process
- Early-Career Awards
- Mid-Career Awards
- Diversity Applicants and Minority-Serving Institutions
- Institutional Awards
- Research Training Committee
- Loan Repayment Program (LRP)
- Research Training Sites
- Blueprint Research Training Sites
- FAQs on New T32 Data Tables
- NIAAA and NIDA to have Institutional NRSA Applications Reviewed by a Common Panel of Experts beginning in 2016
- Mentoring: Key to Building the Pipeline of Addiction Researchers
- Extramural Research Training & Career Development
- News & Events
- News
- Nora's Blog
- NIDA in the News
- NIDA Notes
- NIDA Notes Print Issues
- About NIDA Notes
- NIDA Notes Advanced Search
- Anti-Drug Vaccine Animation
- Podcasts
- Testing a Prospective Medication To Help People Avoid Relapse
- The Rise and Fall of the Cocaine High
- Staff
- Subscribing to NIDA Notes
- El alza y la baja de la euforia causada por la cocaína
- NIDA Notes RSS/Email Subscription
- Why Do People Lose Control Over Their Cocaine Use?
- ¿Por qué las personas pierden el control sobre su consumo de cocaína?
- Podcasts
- E-Newsletters
- Public Education Projects
- Lesson Plan and Activity Finder
- NIDA TV
- PEERx
- USA Science & Engineering Festival
- National Drug & Alcohol Facts Week
- Drugs & Health Blog
- The NIDA Science Fair Award for Addiction Science
- Drugs & Alcohol Chat Day
- HBO Addiction Project
- Learn the Link
- NIDA and Scholastic - Heads Up
- NIDA Media Campaign Postcards
- Public Service Announcements
- Other Government Observances for Substance Abuse Education
- Contact the Press Office
- Meetings & Events
- Media Guide
- Subject Area Experts
- About NIDA
- Director's Page
- Organization
- CCTN
- Intramural Research Program (IRP)
- Divisions
- Division of Epidemiology, Services and Prevention Research (DESPR)
- Division of Extramural Research (DER)
- DER Office of the Director (OD)
- Office of Extramural Policy and Review (OEPR)
- Grants Management Branch (GMB)
- Grant Information Request Sheet or "Just-in-Time"
- Administrative Supplement Requests for NIDA Grants and Cooperative Agreements
- Application instructions for R00 Transition Applications
- Carryover of an Unobligated Balance for NIDA Grants without Automatic Carryover Authority
- Carryover of an Unobligated Balance for NIDA Training Grants (T32s & T90s)
- Change of Recipient Institution (Transfer) for NIDA Grants and Cooperative Agreements
- No-Cost Extensions for NIDA Grants and Cooperative Agreements
- Request for Change of Principal Investigator
- Staff Listings
- Division of Neuroscience and Behavior (DNB)
- Program Areas
- Strategic Plan
- DNB Office of the Director (OD)
- Behavioral and Cognitive Neuroscience Branch (BCN)
- Chemistry and Pharmacology Branch (CP)
- Genetics, Epigenetics, and Developmental Neuroscience Branch (GEDN)
- Integrative Neuroscience Branch (INB)
- Related Funding Opportunities
- DNB Staff Listings
- Division of Therapeutics and Medical Consequences (DTMC)
- Cross-Cutting Research Teams, Workgroups, Interest Groups and Consortia
- Analytics Cross-Cutting Team (ACCT)
- Brain Development Research Consortium
- Cannabis Science Interest (CSI) Group
- Genetics and Epigenetics CCRT
- Funding for Genetics Research
- NIDA Genetics Consortium (NGC)
- Human Genetics Grant Application Guidelines
- NIH and NIDA Data Sharing Policies
- Use NIH RePORTER to see NIDA Genetics Portfolio
- Selected Publications on the Genetics of Addiction
- Compilation of Genetics Resource Databases
- Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1) PAR-18-226 - FAQs
- Nicotine and Tobacco Research Team (NTRT)
- NIDA-NIAAA Neuroscience Workgroup
- Prescription Opioid and Pain Workgroup (POP)
- Women & Sex/Gender Differences Research Group
- Offices
- Legislative Activities
- Budget Information
- Fiscal Year 2019 Budget Information
- Fiscal Year 2018 Budget Information
- Fiscal Year 2017 Budget Information
- Amounts Available for Obligation Table
- Budget Mechanism Table
- Summary of Changes
- Budget Authority by Activity Table
- Authorizing Legislation Table
- Appropriations History Table
- Budget Authority by Object Class Table
- Salaries and Expenses Table
- Details of Full-Time Equivalent Employment (FTE) Table
- Detail of Positions Table
- Fiscal Year 2016 Budget Information
- Amounts Available for Obligation Table
- Budget Mechanism Table
- Summary of Changes
- Budget Authority by Activity Table
- Authorizing Legislation Table
- Appropriations History Table
- Budget Authority by Object Table
- Salaries and Expenses Table
- Details of Full-Time Equivalent Employment (FTEs) Table
- Detail of Positions Table
- Fiscal Year 2015 Budget Information
- Amounts Available for Obligation Table
- Budget Mechanism Table
- Summary of Changes Table
- Budget Authority by Activity Table
- Authorizing Legislation Table
- Appropriations History Table
- Budget Authority by Object Table
- Salaries and Expenses Table
- Details of Full-Time Equivalent Employment (FTEs) Table
- Detail of Positions Table
- Fiscal Year 2014 Budget Information
- Amounts Available for Obligation Table
- Budget Mechanism Table
- Summary of Changes Table
- Budget Authority by Activity Table
- Authorizing Legislation Table
- Appropriations History Table
- Budget Authority by Object Table
- Salaries and Expenses Table
- Details of Full-Time Equivalent Employment (FTEs) Table
- Detail of Positions Table
- Budget Information
- Advisory Boards & Groups
- National Advisory Council on Drug Abuse (NACDA)
- What Council is and What it Does
- Council Roster
- Agenda
- Council Meeting Minutes
- 129th Meeting Minutes
- 128th Meeting Minutes
- 127th Meeting Minutes
- 126th Meeting Minutes
- 125th Meeting Minutes
- 124th Meeting Minutes
- 123rd Meeting Minutes
- 122nd Meeting Minutes
- 121st Meeting Minutes
- 120th Meeting Minutes
- 119th Meeting Minutes
- 118th Meeting Minutes
- 117th Meeting Minutes
- 116th Meeting Minutes
- 115th Meeting Minutes
- 114th Meeting Minutes
- 113th Meeting Minutes
- 112th Meeting Minutes
- 111th Meeting Minutes
- 110th Meeting Minutes
- 109th Meeting Minutes
- 108th Meeting Minutes
- 106th Meeting Minutes
- 107th Meeting Minutes
- 105th Meeting Minutes
- 104th Meeting Minutes
- CRAN Joint Council Meeting Minutes
- Council Statements
- Meeting Dates
- Council Reports
- Charter
- Director's Reports
- NACDA Approved Concepts
- Scientific Review Group/Committee Structure
- National Advisory Council on Drug Abuse (NACDA)
- Working at NIDA
- Donating to NIDA
- Frequently Asked Questions
- Contact Us
- Sharing Tools and Badges
- Other Resources
- Strategic Plan
Publications
- Alucinógenos y drogas disociativas
- Marihuana
- Publications
- Research Reports
- Hallucinogens and Dissociative Drugs
- Anabolic Steroid Abuse
- Cocaine
- Heroin
- Tobacco/Nicotine
- Comorbidity: Addiction and Other Mental Illnesses
- HIV/AIDS
- Inhalants
- MDMA (Ecstasy) Abuse
- Methamphetamine
- Prescription Drug Abuse
- Prescription Opioids and Heroin
- Substance Use in Women
- Therapeutic Communities
- Marijuana
- Medications to Treat Opioid Addiction
- Brain Power
- Preventing Drug Abuse among Children and Adolescents
- Principles of Drug Addiction Treatment
- Principles of Drug Abuse Treatment for Criminal Justice Populations
- Resource Guide
- The Science of Addiction
- Marijuana: Facts Parents Need to Know
- Marijuana: Facts for Teens
- Media Guide
- Mentoring: A Guide for Drug Abuse Researchers
- The Brain: Understanding Neurobiology Through the Study of Addiction
- Community Monitoring Systems
- Drugs: Shatter the Myths
- Seeking Drug Abuse Treatment
- Drugs + Your Body: It Isn’t Pretty (Teaching Guide) Poster
- Family Checkup
- Heads Up: Drugs & The Body Poster
- Marijuana: Download the Facts Poster (Teaching Guide)
- Marijuana: Download the Facts Spanish & English Poster
- NIDA and Scholastic
- National Drug & Alcohol IQ Challenge
- Patient-Physician Conversation Poster
- Prescription Drug Poster
- Principles of Adolescent Substance Use Disorder Treatment: A Research-Based Guide
- Research Training at NIDA
- Principles of Substance Abuse Prevention for Early Childhood
- Research Reports
- Abuso de la MDMA (éxtasis)
- Anabolic Steroids
- Cocaine
- Opiáceos
- Abuso y adicción a la metanfetamina
- Hallucinogens
- Inhalantes
- Adicción al tabaco
- Alucinógenos
- Inhalants
- Abuso de los esteroides anabólicos
- Esteroides anabólicos
- Marijuana
- Estimulantes
- La heroína: Abuso y adicción
- Methamphetamine
- Cocaína: Abuso y adicción
- Nicotina
- Opioids
- Abuso de inhalantes
- Metanfetamina
- Prescription Drugs
- Abuso de la marihuana
- Medicamentos de prescripción
- Medicamentos para el tratamiento del trastorno por consumo de opioides
- Nicotine
- El VIH/SIDA
- Teacher's Guide
- Medicamentos de Prescripción: Abuso y Adicción
- Chequeo Familiar
- Complete Set
- Las drogas y el cerebro
- Principles of Substance Abuse Prevention for Early Childhood A Research-Based Guide (In Brief)
- Publicaciones
- Hechos sobre la marihuana para adolescentes
- Marihuana: Información que los padres deben conocer
- Juventud latina
- Principios de tratamientos para la drogadiccion
- Las drogas, el cerebro y la conducta: la ciencia de la adicción
- Cómo prevenir el uso de drogas
- Desafío nacional sobre el Coeficiente Intelectual (IQ) de las drogas
- Drogas: Derribemos los mitos
- Los opioides: Información para adolescentes
- Qué preguntar al buscar tratamiento para la drogadicción
- The Brain & the Actions of Cocaine, Opiates, and Marijuana
- The Neurobiology of Drug Addiction
- The Neurobiology of Ecstasy
- The Power of Science
- Understanding Drug Abuse and Addiction
Secondary menu
- Researchers
- Research Resources
- Data Harmonization Projects
- Seek, Test, Treat and Retain
- Genetics Data Harmonization
- NGC Domain #1: Largest number of a particular substance used in 24 hour period (Quantity)
- NGC Domain #2: Number of drugs used daily
- NGC Domain #3: Duration of drug use
- NGC Domain #4: Early drug experience (initial liking)
- NGC Domain #5: Total number of symptoms
- NGC Domain #6: Environmental variables
- NGC Domain #7: Age of onset
- NGC Domain #8: Was drug available to you
- NGC Domain #9: Would you take the drug if it were available to you
- NGC Domain #10: Withdrawal, repeated difficulty with cessation/quitting
- NGC Domain #11: Family history information
- NGC Domain #12: Other symptoms (e.g. Depression)
- NGC Domain #13: Other Factors
- FAQs - Clinical Studies Involving Electronic Cigarettes and INDs
- Justice System Research
- CJ-DATS-2 Research Centers
- CJ-DATS-2 Studies
- CJ-DATS-1 Research Centers
- CJ-DATS-1 Studies - Adolescent Interventions
- CJ-DATS-1 Studies - Assessing Offender Problems
- CJ-DATS-1 Studies - HIV and Hepatitis Risk Reduction
- CJ-DATS-1 Studies - Linking Criminal Justice and Drug Abuse
- CJ-DATS-1 Studies - Measuring Progress in Treatment and Recovery
- CJ-DATS-1 Studies - Understanding Systems
- CJ-DATS Bibliography
- JJ-TRIALS Cooperative Research Centers
- NIDA Challenges Program
- NIDA Drug Supply Program (DSP)
- NIDA-Tobacco Regulatory Science Program (TRSP)
- Population Assessment of Tobacco and Health (PATH) Study
- Data Harmonization Projects
- Research Resources
- Patients & Families
- Parents & Educators
- Children & Teens
- En español
- NIDAMED: Medical & Health Professionals
- Drug Screening and Assessment Resources
- CTN Dissemination Initiative
- CME/CE
- ADM Fellow Toolkit
- About the Addiction Medicine Subspecialty
- Initiating Buprenorphine Treatment in the Emergency Department
- Buprenorphine Integration Pathway
- Buprenorphine Treatment Algorithm
- Motivating Patients
- A Guide for Patients Beginning Buprenorphine Treatment at Home
- Questions for Identification of Opioid Use Disorder based on DSM-5
- Frequently Asked Questions about ED-Initiated Buprenorphine
- ED-Initiated Buprenorphine - Heroes in Practice
- Science to Medicine: Medication Treatment for Opioid Use Disorder
- Medication Treatment for Opioid Use Disorder in the Emergency Medicine Setting
- Medication Treatment for Opioid Use Disorder in the Federally Qualified Health Center Setting
- Medication Treatment for Opioid Use Disorder in the Pediatric (Adolescent Medicine) Setting
- Medication Treatment for Opioid Use Disorder in the Primary Care Setting
- Spotlight on the Get Waivered Campaign
- Connect with NIDA
- Conéctese con NIDA
- In English
- News
- Opioid Summaries by State
- Alabama
- Alaska
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Delaware
- Florida
- Georgia
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Vermont
- Virginia
- Washington
- Washington D.C.
- West Virginia
- Wisconsin
- Wyoming